A new, independently conducted clinical study in Experimental and Clinical Psychopharmacology offers rare, high-quality evidence on how oral nicotine pouches perform for people who already use smokeless tobacco (SLT) and why nicotine content is the hinge on which substitution success turns. What the study asked and why it matters Alisha Eversole and colleagues at Virginia…
At InterTabac, GINN’s Phil Hudson sat down with Hannu Karvonen, representing Denssi nicotine pouches, a Finnish brand making waves in Europe and beyond. In their conversation, Karvonen shared how Denssi is balancing product innovation, global expansion, and new category development to meet changing consumer demands. From Finland to the World Denssi’s story begins in Finland,…
At InterTabac 2025, GINN’s Phil Hudson sat down with Shivam Bihani, co-founder of MYNT Nicotine Pouches, to discuss the company’s origins, market growth, and vision for the future of oral nicotine. The conversation revealed how MYNT, founded in 2020 in Gujarat, India, has quickly become a global player in tobacco harm reduction. From India to…
Policies meant to restrict access to nicotine pouches are turning out to be counterproductive, especially for workers, whose access to tobacco alternatives is already constrained by time, location, and economic pressures. In New Brunswick, Canada, a construction worker’s story powerfully illustrates the human cost when safer options are forced off convenience shelves and buried behind…
At the New Approaches Summit 2025, the conversation around oral pouches moved beyond nicotine. What began as a harm reduction innovation has now evolved into a platform with potential far beyond smoking alternatives. Oral pouches, once defined by snus and nicotine, are being reimagined as discreet, fast-acting vehicles for functional microdosing and even emerging therapeutic…
On the evening of 18 September 2025, the PouchXchange event at InterTabac – InterSupply in Dortmund brought together leading figures in the oral nicotine products sector. Organized as an industry gathering focused on compliance, commerce, and connection, the evening underscored how rapidly the nicotine pouch and next-gen oral market is evolving. GINN served as a…
Bangladesh is at a crossroads in its fight against tobacco. Despite decades of tobacco control policies, the country still faces some of the highest smoking and smokeless tobacco use rates in the world. More than 35 million adults consume tobacco in some form, and the toll on public health is devastating: over 161,000 people die…
In September 2025, France confirmed plans to ban the sale of nicotine pouches starting in 2026, a move hailed by anti-tobacco groups but criticized by harm reduction advocates as a serious setback for public health. The Ban and Its Rationale French authorities justified the ban as a measure to protect young people, pointing to rising…
The U.S. Food and Drug Administration (FDA) is accelerating its review of nicotine pouches, responding to mounting pressure from the White House to clarify the regulatory status of one of the fastest-growing categories in tobacco harm reduction. A Rapidly Expanding Market in Limbo Nicotine pouches, tobacco-free oral sachets delivering nicotine without combustion, have surged in…
GINN is delighted to welcome Asian Trade Media Group as both our newest member and media partner, an important step that strengthens our mission to build a global community grounded in science, compliance, and responsible growth. About Asian Trade Media Group As the team behind the widely respected AsianTrader.biz, Asian Trade Media Group brings decades…